Andrea Loewen's Insider Trades & SAST Disclosures

Andrea Loewen's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 6,750 Class A common stock done at an average price of $86.3 . Disclosure was reported to the exchange on May 12, 2023.

Share

Note

This is a custom search result for pattern Andrea Loewen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 86.26 per share.	12 May 2023	6,750	32,007 (0%)	0%	86.3	582,267	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 81.02 per share.	12 May 2023	313	31,591 (0%)	0%	81.0	25,359	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 84.71 per share.	12 May 2023	103	31,904 (0%)	0%	84.7	8,725	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 83.36 per share.	07 Mar 2023	17,836	39,957 (0%)	0%	83.4	1,486,809	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2023	15,000	35,000	-		-	Employee Stock Option (right to buy)
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.32 per share.	07 Mar 2023	15,000	57,793 (0%)	0%	27.3	409,800	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 84.44 per share.	07 Mar 2023	1,200	38,757 (0%)	0%	84.4	101,328	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 87.73 per share.	02 Mar 2023	1,601	42,793 (0%)	0%	87.7	140,456	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Sale of securities on an exchange or to another person at price $ 90.61 per share.	02 Mar 2023	218	44,394 (0%)	0%	90.6	19,753	Class A common stock
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	47,738	47,738	-		-	Employee Stock Option (right-to-buy)
Reata Pharmaceuticals Inc ...	Andrea Loewen	SVP, Global Regulatory Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	11,756	44,612 (0%)	0%		0	Class A common stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades